SBIR Phase I: COVID-19-impermeable high-performance porous coatings for respiratory personal protective equipment
SBIR 第一阶段:用于呼吸个人防护设备的 COVID-19 不渗透高性能多孔涂层
基本信息
- 批准号:2034453
- 负责人:
- 金额:$ 25.6万
- 依托单位:
- 依托单位国家:美国
- 项目类别:Standard Grant
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-08-01 至 2022-01-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
The broader impact/commercial potential of this Small Business Innovation Research (SBIR) project encompasses development new coatings for face masks and filtration pieces for N95-grade respirators. The outer layer will repel the viral particles while the inner layer will adsorb moisture, making the mask comfortable for wear and assisting with social distancing compliance during the COVID-19 pandemic. The coatings are efficient in their function, provide reliable protection, and are durable. This technology is also highly promising for applications in other types of personal protective equipment such as gowns, drapes, medical aprons, as well as coatings on disposable medical devices. Apart from the medical sector, this platform has potential advantages for other goods, pharmaceutical formulations, and personal care products. This SBIR Phase I project proposes to develop innovative formulations for deposition of high-performance superhydrophobic and superhydrophilic coatings on textile surfaces for personal protective equipment. The technical innovation is fabrication of novel dendritic polymer particles with extraordinary high surface area and unusually strong adhesivity. The soft dendritic colloids are formed when a polymer solution is injected into turbulently sheared anti-solvent medium. Random stretching of the polymer solution droplets by the turbulent anti-solvent flow causes the polymer to precipitate in the form of soft dendritic structures. The critical technical hurdle is scaling manufacturing of large volumes of soft dendritic particles with fractal morphology. Technical objectives are: 1) develop an efficient liquid-based process for soft dendritic colloids fabrication on a bench scale; and 2) characterize textiles coated with the new formulations using a series of morphological, filtration efficiency, and breathability tests.This award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the Foundation's intellectual merit and broader impacts review criteria.
这项小企业创新研究(SBIR)项目的更广泛影响/商业潜力包括开发新的口罩涂层和n95级呼吸器过滤片。外层将排斥病毒颗粒,内层将吸附水分,使口罩佩戴舒适,并有助于在COVID-19大流行期间保持社交距离。该涂层具有高效的功能,提供可靠的保护,并且经久耐用。这项技术也非常有希望应用于其他类型的个人防护设备,如长袍、窗帘、医疗围裙,以及一次性医疗设备的涂层。除医疗行业外,该平台在其他商品、药品配方和个人护理产品方面也具有潜在优势。该SBIR一期项目建议开发创新配方,用于在纺织品表面沉积用于个人防护装备的高性能超疏水和超亲水涂层。该技术的创新之处在于制造出具有超高表面积和异常强附着力的新型枝状聚合物颗粒。将聚合物溶液注入湍流剪切的抗溶剂介质中形成软枝状胶体。聚合物溶液液滴被湍流的反溶剂流动随机拉伸,导致聚合物以软枝晶结构的形式沉淀。关键的技术障碍是大规模制造具有分形形态的软枝晶颗粒。技术目标是:1)在实验规模上开发一种高效的基于液体的软枝晶胶体制造工艺;2)使用一系列形态学、过滤效率和透气性测试来表征涂有新配方的纺织品。该奖项反映了美国国家科学基金会的法定使命,并通过使用基金会的知识价值和更广泛的影响审查标准进行评估,被认为值得支持。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Anka Veleva其他文献
Anka Veleva的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Anka Veleva', 18)}}的其他基金
SBIR Phase II: Lignin-Based Formulations for Efficient and Sustainable Control of Plant Pathogens
SBIR 第二阶段:用于有效和可持续控制植物病原体的木质素配方
- 批准号:
1950915 - 财政年份:2020
- 资助金额:
$ 25.6万 - 项目类别:
Standard Grant
SBIR Phase I: Lignin-Based Formulations for Efficient and Sustainable Control of Plant Pathogens
SBIR 第一阶段:基于木质素的制剂,用于有效和可持续地控制植物病原体
- 批准号:
1746692 - 财政年份:2018
- 资助金额:
$ 25.6万 - 项目类别:
Standard Grant
STTR Phase I: Novel Molecularly Targeted Tracer for Specific and Sensitive Imaging of Cancer
STTR 第一阶段:用于癌症特异性和灵敏成像的新型分子靶向示踪剂
- 批准号:
1321424 - 财政年份:2013
- 资助金额:
$ 25.6万 - 项目类别:
Standard Grant
相似国自然基金
Baryogenesis, Dark Matter and Nanohertz Gravitational Waves from a Dark
Supercooled Phase Transition
- 批准号:24ZR1429700
- 批准年份:2024
- 资助金额:0.0 万元
- 项目类别:省市级项目
ATLAS实验探测器Phase 2升级
- 批准号:11961141014
- 批准年份:2019
- 资助金额:3350 万元
- 项目类别:国际(地区)合作与交流项目
地幔含水相Phase E的温度压力稳定区域与晶体结构研究
- 批准号:41802035
- 批准年份:2018
- 资助金额:12.0 万元
- 项目类别:青年科学基金项目
基于数字增强干涉的Phase-OTDR高灵敏度定量测量技术研究
- 批准号:61675216
- 批准年份:2016
- 资助金额:60.0 万元
- 项目类别:面上项目
基于Phase-type分布的多状态系统可靠性模型研究
- 批准号:71501183
- 批准年份:2015
- 资助金额:17.4 万元
- 项目类别:青年科学基金项目
纳米(I-Phase+α-Mg)准共晶的临界半固态形成条件及生长机制
- 批准号:51201142
- 批准年份:2012
- 资助金额:25.0 万元
- 项目类别:青年科学基金项目
连续Phase-Type分布数据拟合方法及其应用研究
- 批准号:11101428
- 批准年份:2011
- 资助金额:23.0 万元
- 项目类别:青年科学基金项目
D-Phase准晶体的电子行为各向异性的研究
- 批准号:19374069
- 批准年份:1993
- 资助金额:6.4 万元
- 项目类别:面上项目
相似海外基金
SBIR Phase II: Design and production of a next generation vaccine to prevent COVID
SBIR 第二阶段:设计和生产下一代预防新冠病毒的疫苗
- 批准号:
2313338 - 财政年份:2024
- 资助金额:
$ 25.6万 - 项目类别:
Cooperative Agreement
SBIR Phase II: Facilitating Early Childhood Teacher and Family Engagement During COVID-19
SBIR 第二阶段:在 COVID-19 期间促进幼儿教师和家庭的参与
- 批准号:
2151349 - 财政年份:2022
- 资助金额:
$ 25.6万 - 项目类别:
Cooperative Agreement
SBIR Phase II: Machine Learning for Rapid Automated Viral Infectivity Assays (COVID-19)
SBIR 第二阶段:用于快速自动化病毒感染性检测的机器学习 (COVID-19)
- 批准号:
2136850 - 财政年份:2022
- 资助金额:
$ 25.6万 - 项目类别:
Cooperative Agreement
SBIR Phase I: A platform for simulating the combined effect of human behavior and environment on airborne infectious spread (COVID-19)
SBIR 第一阶段:模拟人类行为和环境对空气传播传染病(COVID-19)综合影响的平台
- 批准号:
2151672 - 财政年份:2022
- 资助金额:
$ 25.6万 - 项目类别:
Standard Grant
SBIR Phase II: Microbial Discovery and Biosynthesis of Targeted Protease Inhibitors (COVID-19)
SBIR 第二阶段:微生物发现和靶向蛋白酶抑制剂(COVID-19)的生物合成
- 批准号:
2213051 - 财政年份:2022
- 资助金额:
$ 25.6万 - 项目类别:
Cooperative Agreement
SBIR Phase I: Continuous Manufacturing for Nucleic Acid Lipid Nanoparticles to Improve the Supply Chain of Therapeutics and Vaccines (COVID-19)
SBIR 第一阶段:连续生产核酸脂质纳米粒子,以改善治疗药物和疫苗的供应链 (COVID-19)
- 批准号:
2151477 - 财政年份:2022
- 资助金额:
$ 25.6万 - 项目类别:
Standard Grant
SBIR Phase II: Stress Pathway Inhibition To Prevent COVID-19 Infection (COVID-19)
SBIR 第二阶段:通过抑制应激途径预防 COVID-19 感染 (COVID-19)
- 批准号:
2150149 - 财政年份:2022
- 资助金额:
$ 25.6万 - 项目类别:
Cooperative Agreement
SBIR Phase II: COVID-19 Rapid Sensing Using Structural DNA Biosensors
SBIR 第二阶段:使用结构 DNA 生物传感器快速检测 COVID-19
- 批准号:
2127436 - 财政年份:2022
- 资助金额:
$ 25.6万 - 项目类别:
Cooperative Agreement
SBIR Phase I: Ace2 decoy as a pan-coronavirus therapeutic (COVID-19)
SBIR 第一阶段:Ace2 诱饵作为泛冠状病毒治疗药物 (COVID-19)
- 批准号:
2136508 - 财政年份:2022
- 资助金额:
$ 25.6万 - 项目类别:
Standard Grant
SBIR Phase II: A Rapid, Sensitive Pathogen Typing and Antibiotic Sensitivity Test for Bloodstream Infections (COVID-19)
SBIR II 期:针对血流感染 (COVID-19) 的快速、敏感病原体分型和抗生素敏感性测试
- 批准号:
2212920 - 财政年份:2022
- 资助金额:
$ 25.6万 - 项目类别:
Cooperative Agreement














{{item.name}}会员




